Found 5 matching trials
Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine
PHASE2The purpose of this booster study is to evaluate, in subjects primed in the...
Location
GSK Investigational Site
Study to Evaluate GR1801's Efficacy and Safety
PHASE3The goal of this clinical trial is to compare the efficacy and safety of GR...
Location
Center for Disease Control and Prevention (CDC)
Post-marketing Safety Study of GSK Biological's Pediarix™ Vaccine
N/APre-licensure studies of GSK Biologicals' PEDIARIX vaccine have shown it to...
Location
Multiple Locations
US-licensed Combined Vaccine Against Tetanus & Diphtheria, Given With US-licensed Vaccine Against Meningococcal Disease
PHASE4New immunization recommendations in the US include vaccination of adolescen...
Location
GSK Investigational Site
Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age
PHASE2The purpose of this study is to show that the immunogenicity of newly formu...
Location
GSK Investigational Site